ACE and heart failure: The Change the Management of Patients With Heart Failure (CHAMP-HF) registry [20] showed that ACE inhibitors, ARBs, and ARNIs were titrated to the target dose in only one-quarter to one-fifth of patients, and less than 1% of patients received all three medications.